Thank you very much, Mr. Chair.
Thanks to all the officials for joining us here today.
We've heard some talk about the watch-list. One of the concerns.... I know that a previous answer referred to the classification of substances going on and off the watch-list. However, when looking through the legislation and hearing witness testimony, there is concern that there's not a clearly defined off-ramp for this so-called watch-list. I am wondering if I could get some clarity around why there's a bit of disparity in understanding.